NANOG and cancer: Based on the original concept of the embryonal origin of cancer, and thanks to the advent of scRNA-seq technology, we were able to identify a population of GBM cells with concurrent high levels of the core ESC pluripotency factors OCT4, SOX2, and NANOG.